Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 5,228,300 | 5,760,500 | 5,191,700 | 5,404,800 | 4,865,100 |
| Cost of Goods | 1,347,900 | 1,521,200 | 1,400,900 | 1,465,000 | 1,323,000 |
| Gross Profit | 3,880,400 | 4,239,300 | 3,790,800 | 3,939,800 | 3,542,100 |
| Operating Expenses | 3,898,400 | 3,560,900 | 2,848,200 | 3,016,500 | 2,826,300 |
| Operating Income | -17,100 | 678,599 | 943,500 | 923,300 | 715,800 |
| Other Income | 78,300 | 213,401 | 27,200 | 21,200 | -149,000 |
| Pre-tax Income | 61,200 | 892,000 | 970,700 | 944,500 | 566,800 |
| Income Tax | 172,000 | 120,200 | 192,700 | 196,800 | 126,700 |
| Net Income Continuous | -110,800 | 771,800 | 778,000 | 747,700 | 440,100 |
| Net Income | $-110,800 | $771,800 | $778,000 | $747,700 | $440,100 |
| EPS Basic Total Ops | -0.10 | 0.72 | 0.74 | 0.71 | 0.42 |
| EPS Basic Continuous Ops | -0.10 | 0.73 | 0.74 | 0.71 | 0.42 |
| EPS Diluted Total Ops | -0.10 | 0.73 | 0.73 | 0.71 | 0.41 |
| EPS Diluted Continuous Ops | -0.10 | 0.73 | 0.73 | 0.71 | 0.41 |
| EBITDA(a) | $369,800 | $1,023,199 | $1,336,300 | $1,297,000 | $1,101,300 |